Psychiatric Section, Department of Neuroscience, University of Parma Parma, Italy.
Neuropsychiatr Dis Treat. 2008 Feb;4(1):93-106. doi: 10.2147/ndt.s1557.
Panic disorder (PD) is a disabling condition which appears in late adolescence or early adulthood and affects more frequently women than men. PD is frequently characterized by recurrences and sometimes by a chronic course and, therefore, most patients require long-term treatments to achieve remission, to prevent relapse and to reduce the risks associated with comorbidity. Pharmacotherapy is one of the most effective treatments of PD. In this paper, the pharmacological management of PD is reviewed. Many questions about this effective treatment need to be answered by the clinician and discussed with the patients to improve her/his collaboration to the treatment plan: which is the drug of choice; when does the drug become active; which is the effective dose; how to manage the side effects; how to manage nonresponse; and how long does the treatment last. Moreover, the clinical use of medication in women during pregnancy and breastfeeding or in children and adolescents was reviewed and its risk-benefit balance discussed.
惊恐障碍(PD)是一种致残性疾病,多在青少年晚期或成年早期出现,且女性发病率高于男性。PD 常反复发作,有时呈慢性病程,因此大多数患者需要长期治疗以达到缓解,预防复发,并降低共病相关风险。药物治疗是 PD 最有效的治疗方法之一。本文综述了 PD 的药物治疗管理。临床医生需要回答许多关于这种有效治疗的问题,并与患者讨论,以提高患者对治疗计划的配合度:哪种药物是首选;药物何时起效;有效剂量是多少;如何处理副作用;如何处理无应答;治疗持续多长时间。此外,还回顾了药物在妊娠期和哺乳期妇女、儿童和青少年中的临床应用,并讨论了其风险-效益平衡。